Drug Profile
Polymeric bone adhesive - SBPM
Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator SBPM
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bone disorders
Most Recent Events
- 28 Oct 1998 Preclinical development for Bone disorders in Israel (Intralesional)